Global Biopharmaceutical Company - Bristol Myers Squibb

2022 Second Quarter Results >

Bristol Myers Squibb reports second quarter revenues of $11.9 Billion; GAAP EPS of $0.66 and non-GAAP EPS of $1.93 which include net impact of ($0.14) per share due to acquired IPRD charges and licensing income. Read more, including important cautionary statements about forward-looking information.

Our R&D Team  >

Learn more about the backgrounds, scientific pursuits and personal interests of members of our research team.

Our presence in Washington >

Bristol Myers Squibb’s robust and growing presence in Washington is transforming the way cancer and other difficult-to-treat diseases are approached.

Survivorship Today

Emmy winner Sterling K. Brown explores cancer survivorship during a global pandemic.

Learn More >

Moving forward.


We’re looking for people who want to change lives.  Join us as we transform patients’ lives through science. 


Learn more about how we strive to produce sustained strong performance and shareholder value.

Looking for Answers?

Quick links to helpful resources.

Clinical Trial Information for Researchers
Clinical trials and research are a critical part of bringing new medicines to patients.

Medical Information for Healthcare Providers
Information and resources to assist with caring for patients.

Help Paying for Your Medicines
If you are a patient in the U.S. struggling to understand your coverage or pay for your medication, we may be able to help.